Podcast
June 8, 202633 min

Bariatric Surgery After GLP-1s: What We Learned at ASMBS 2026

Bariatric Surgery After GLP-1s: What We Learned at ASMBS 2026 podcast artwork

What happens to bariatric surgery when GLP-1 medications like Ozempic, Wegovy, and Zepbound change the entire weight loss landscape? In this episode, Dr. Matthew Weiner and registered dietitian Zoe unpack what they saw at the 2026 ASMBS annual conference - a meeting that felt very different from prior years. Surgical volumes are down, many bariatric surgeons are wrestling with what GLP-1s mean for their practices, and patients are left trying to figure out whether medication, nutrition, surge...

Podcast Summary

Bariatric Surgery in the Age of GLP-1 Medications: Key Insights from ASMBS 2026

The weight loss landscape is shifting dramatically. GLP-1 medications like Ozempic, Wegovy, and Zepbound have changed how patients and physicians approach obesity treatment. At the 2026 American Society for Metabolic and Bariatric Surgery (ASMBS) conference, the mood was noticeably different from previous years.

Dr. Matthew Weiner and registered dietitian Zoe attended this important gathering and returned with valuable insights for patients navigating their weight loss options. The conversations at this year's conference reflected a field in transition, where medication and surgery are being reconsidered as complementary rather than competing approaches.

What's Happening with Bariatric Surgery Volumes

Talk with our team

Have questions about this episode?

Send our Tucson weight loss team a note about bariatric surgery, GLP-1 medications, nutrition, or your next step with Pound of Cure.

More from this episode

Bariatric surgery numbers are declining across the country. This trend has caught the attention of surgeons, healthcare systems, and patients alike. The widespread availability of GLP-1 medications has given many people an alternative to surgery that feels less invasive and more accessible.

Many bariatric surgeons are grappling with what this shift means for their practices. Some are adapting by incorporating medical weight management into their services. Others are focusing on patient populations who may benefit most from surgical intervention. The field is evolving, and practitioners are learning to navigate this new reality.

For patients, this creates both opportunities and challenges. Having more treatment options is positive, but knowing which path to choose requires careful consideration and expert guidance.

The Relationship Between GLP-1 Medications and Surgery

One of the most important discussions at the conference centered on how GLP-1 medications and bariatric surgery can work together. These are not necessarily either-or decisions. Some patients may start with medication and later choose surgery. Others might use medication before surgery to optimize their health. Still others may need medication support after surgery to maintain their results.

The metabolic benefits of bariatric surgery remain significant. Surgery often provides more dramatic and sustained weight loss than medication alone. It can also lead to improvement or remission of conditions like type 2 diabetes, high blood pressure, and sleep apnea.

GLP-1 medications offer their own advantages. They are non-surgical, can be started and stopped, and have become increasingly effective with newer formulations. However, they typically require long-term use, can be expensive, and may not provide the same degree of metabolic improvement as surgery for some patients.

Who Should Consider Surgery Versus Medication

The decision between bariatric surgery and GLP-1 medications depends on multiple factors:

  • Severity of obesity and related health conditions
  • Previous weight loss attempts and results
  • Personal preferences regarding surgery versus long-term medication
  • Insurance coverage and financial considerations
  • Long-term health goals and metabolic disease risk
  • Response to initial medication trials

Patients with severe obesity and multiple metabolic conditions may achieve better long-term outcomes with surgery. Those with less severe obesity or concerns about surgical risks might do well with medication. The key is personalized assessment by qualified healthcare providers.

The Role of Nutrition Remains Central

Regardless of whether patients choose medication, surgery, or both, nutrition plays a critical role in success. This was a consistent theme at the ASMBS conference. Neither GLP-1 medications nor bariatric surgery eliminate the need for healthy eating patterns.

Medications can reduce appetite, but patients still need to make nutritious food choices to support their health. Surgery changes the anatomy of digestion, but dietary habits determine long-term outcomes. Working with experienced dietitians helps patients maximize their results with either approach.

Pound of Cure emphasizes the importance of nutritional support throughout the weight loss journey. Whether you are considering medication, preparing for surgery, or maintaining your weight loss, proper nutrition provides the foundation for lasting success.

What This Means for Patients Today

The weight loss field is more complex than ever, but also more hopeful. Patients today have effective options that previous generations lacked. The key is finding the right approach for your individual situation.

If you are considering weight loss treatment, seek out providers who understand both medical and surgical options. The best practitioners will help you weigh the benefits and limitations of each approach without pushing a predetermined agenda.

Metabolic health extends beyond the number on the scale. Whether through medication, surgery, lifestyle changes, or a combination of approaches, the goal is sustainable improvement in overall health and quality of life.

Looking Forward

The conversations at ASMBS 2026 revealed a field adapting to rapid change. Bariatric surgery is not disappearing, but it is finding its place alongside powerful new medications. Surgeons, physicians, and dietitians are learning to work together to provide comprehensive care.

For patients in Tucson and beyond, this evolution means more personalized treatment options. The future of weight loss medicine involves matching the right intervention to the right patient at the right time. As research continues and practices adapt, patients will benefit from increasingly sophisticated approaches to obesity treatment.

The most important takeaway is this: whether you choose medication, surgery, or another path, you deserve expert guidance that considers your unique needs and goals. The changing landscape of weight loss treatment offers new hope for lasting success.

Weight loss topics covered in this episode

This conversation is part of the Pound of Cure approach to evidence-based weight loss education, including bariatric surgery, GLP-1 medications, nutrition counseling, metabolic health, and long-term patient support.

For more context, explore our guides to GLP-1 medications, bariatric surgery in Tucson, and the Metabolic Reset Diet.